Spave Science Inc. is a pre-clinical stage company that develops medicines for nervous system dysfunctions. We aim to change the disease trajectory by stopping acute cell death and secondary cascades and restoring nervous dysfunction through neuroplasticity. We focus on therapeutic areas with high unmet needs such as traumatic vision and brain injury, neurodegenerative diseases, depression, and stroke.
